Advancing Telestroke Care: A Prospective Observational Study
ATC
1 other identifier
observational
508
1 country
1
Brief Summary
This study will promote the development and economic sustainability of telemedicine for acute stroke treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2010
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2010
CompletedFirst Posted
Study publicly available on registry
October 22, 2010
CompletedStudy Start
First participant enrolled
December 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedDecember 5, 2013
December 1, 2013
2.4 years
October 20, 2010
December 4, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IV tPA administration
Correctness of decisions regarding IV tPA administration in acute stroke
Day 7/Discharge
Secondary Outcomes (1)
Multiple Study Assessments
Day 7 and/or Day 30 and/or Day 90 and/or at discharge
Study Arms (3)
Hub Hospital
Hub Hospital Cohort: Joint Commission-certified Primary Stroke Centers where patients are treated using hospital-based stroke teams and pathways; these hospital personnel also provide telemedicine consultation to satellite hospitals.
Spoke Hospital
Spoke Hospital Cohort: non-stroke center certified sites, where patients are treated at an in-network telestroke community hospital using telemedicine technology with consultation provided by physicians from a hub hospital.
Control Hospital
Control Hospital Cohort: non-stroke center certified sites with no telemedicine services.
Eligibility Criteria
600 subjects meeting inclusion and exclusion criteria will be enrolled consecutively over approximately 12 months and followed for 90 days post-stroke.
You may qualify if:
- Age greater than or equal to 18 years old
- Acute ischemic stroke within 12 hours of stroke onset
You may not qualify if:
- Life expectancy less than 90 days
- Patient unwilling to participate in study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Stroke Association, United Stateslead
- University of Southern Californiacollaborator
- Mayo Cliniccollaborator
- Swedish Medical Centercollaborator
- University of Utahcollaborator
- California Pacific Medical Centercollaborator
Study Sites (1)
University of Southern California
Los Angeles, California, 90033, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gene Sung, MD, MPH
University of Southern California, Los Angeles
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2010
First Posted
October 22, 2010
Study Start
December 1, 2010
Primary Completion
May 1, 2013
Study Completion
December 1, 2013
Last Updated
December 5, 2013
Record last verified: 2013-12